Analyst consensus rating
MetLife Analyst Rating: Buy
MET is rated Buy by 16 analysts with a $105.06 target. As of 2026-08-31.
Direct answer
MetLife's consensus rating is Buy.
16 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $105.06.
Forecast evidence checked August 31, 2026.
Get free MetLife email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $95.65
- Average price target
- $105.06
- High price target
- $119.00
- Low price target
- $84.00
- Low target gap
- -12.2%
- Target upside
- +9.8%
- High target gap
- +24.4%
- Target range width
- 36.6%
- Consensus rating
- Buy
- Analysts
- 16
- Evidence date
- August 31, 2026
- Valid through
- September 7, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for MetLife?
MetLife has a verified Buy consensus. The same dataset has an average price target of $105.06.
How far are MetLife's low and high targets from the recorded price?
The low target implies -12.2%, while the high target implies +24.4%.
How many analysts are included in MetLife's consensus?
The verified consensus includes 16 analysts.
How is MetLife's target upside or downside calculated?
The average target of $105.06 is divided by the recorded price of $95.65, then one is subtracted to produce +9.8%. This does not guarantee a future return.
When was MetLife's analyst forecast verified?
The data was verified on 2026-08-31. The dataset is valid through 2026-09-07.